World

T-bills hit by US debt ceiling worries, stocks slip ahead of CPI

May 10, 2023

Washington [US], May 10: A gauge of global equities fell on Tuesday as investors grew cautious ahead of key data on U.S. consumer prices, while the impasse over the U.S. debt ceiling sparked a sharp sell-off in short-dated Treasury bills.
Disappointing forecasts from companies such as PayPal and Apple supplier Skyworks weighed on sentiment as markets awaited a meeting between President Joe Biden and top Republican lawmakers about raising the $31.4 trillion debt ceiling.
Investors fear a government default as early as June 1 if Congress fails to resolve the deadlock. Failure to raise the limit would cause a huge hit to the U.S. economy and weaken the dollar as the world's reserve currency, Treasury Secretary Janet Yellen warned on Monday.
"If Janet Yellen is right about the early June date, you got to be careful about the shorter-dated bills. Our calculation shows she's not incorrect," said Steven Ricchiuto, U.S. chief economist at Mizuho Securities USA LLC in New York.
The yield on 1-month Treasury bills surged 23.8 basis points to hit a high of 5.689% and yields on 2-month bills climbed to a high of 5.283% as investors sold off notes that mature about the time the debt limit could be hit.
Yields on both T-bills slid later while longer-dated Treasury yields edged higher as investors waited for a reading of the U.S. consumer price index on Wednesday that may alter market speculation on when the Fed might cut interest rates.
The market is focused on core CPI and if that remains elevated it would challenge the market's belief that the Fed will cut rates sooner rather than later, said Kevin Flanagan, head of fixed income strategy at WisdomTree.
"I wouldn't be surprised to see the market come off a bit," he said. "Treasury yields I would argue came down too much too soon."
The market expects the CPI index to have gained 0.4% in April from the month before and 5.5% from a year earlier on a non-seasonally adjusted basis, a Reuters poll of economists shows.
The two-year Treasury yield, which typically moves in step with interest rate expectations, rose 1.2 basis points to 4.024%.
The dollar edged higher against major currencies, with the dollar index up 0.168%.
MSCI's gauge of global equity performance (.MIWD00000PUS) closed down 0.46% after customs data showed China's imports contracted sharply in April, while exports rose at a slower pace, reinforcing signs of feeble domestic demand.
"When it comes to the Chinese market, you have the question coming from investors now about the strength of the recovery," said Frank Benzimra, SocieteGenerale's Hong Kong-based head of Asian equity strategy.
A string of downbeat corporate updates soured sentiment in Europe, leading the pan-regional STOXX 600 index (.STOXX) to lose 0.33%.
The Dow Jones Industrial Average (.DJI) fell 0.17%, the S&P 500 (.SPX) lost 0.46% and the Nasdaq Composite (.IXIC) dropped 0.63%.
Oil prices ticked up and reversed a more than 2% drop earlier in the session as markets weighed U.S. government plans to refill the nation's emergency oil reserve and anticipated higher seasonal demand.
Brent crude settled up 43 cents, or 0.6% higher, at $77.44 a barrel, while U.S. West Texas Intermediate (WTI) crude closed up 55 cents or 0.8% at $73.71.
Gold gained as investors sought cover from economic uncertainty while positioning for the U.S. inflation data for clues on the trajectory of interest rates.
U.S. gold futures settled 0.5% higher at $2,042.90 an ounce.
Source: Fijian Broadcasting Corporation

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024